Here to listen, inform & support - For general enquiries call 01223-870008

Clinical Trials

Clinical Trials Every year, more than half a million people help the NHS improve healthcare and develop life-saving treatments by taking part in clinical trials. This is the UK Clinical Trials Gateway web site which provides information about clinical trials running in the UK and is designed to enable you and your clinician to locate and contact...
Read More

Mixed results for Opdivo/ Yervoy combo

A combination of Bristol-Myers Squibb’s Opdivo (nivolumab)and Yervoy (ipilimumab) has failed to significantly improve progression-free survival (PFS) compared to Pfizer’s Sutent in patients with renal cancer. The firm said that the Phase III CheckMate-214 study missed one of its co-primary endpoints in that there was no significant difference in PFS in intermediate and poor-risk patients with...
Read More

Shorter Telomere Length Predicts Cancer in Patients With VHL

Shorter blood telomere length is a biomarker for tumor risk in patients with Von Hippel-Lindau (VHL) syndrome, according to an article published in Cancer Medicine.1 VHL, which affects up to 1 in 36,000 people globally, is caused by a germline mutation in the VHL gene, and is associated with a high lifetime risk of multiple...
Read More

microRNAs and the Future of Renal Cell Carcinoma Treatment

Researchers in America are zeroing in on microRNAs (miRNAs) circulating in the bloodstream as biomarkers for the detection and diagnosis of renal cell carcinoma (RCC), and are increasingly hopeful of unlocking their potential as targeted therapies for combatting the disease. “We know what genes are responsible for RCC, or at least many cases of RCC,”...
Read More

Tests in USA on epacadostat and Keytruda combination

Incyte Corp. and Merck will work together in the USA to study the combination of epacadostat and Keytruda in people fighting several types of cancer. The study will look at melanoma that has spread, nonsmall-cell lung cancer, bladder cancer, renal cell carcinoma, and head and neck squamous cell carcinoma, according to a news announcement. They...
Read More

Update on the Glasgow to Edinburgh Canoe Challenge 2017

Kidney Cancer Scotland had a great meeting with the Glasgow to Edinburgh Canoe Challenge 2017 (#Glas2Ed2017) organisers this week and it’s really picking up pace. We’ve had great interest, so much so we have had to open registration early! It’s £15 to register and that buys you a t-shirt on completion. If you pass on...
Read More
1 2 3 35